In this Issue
- Last-Minute Rule Changes, Opt-Outs, Ahead of Colorado’s Psychedelics Program Launch
- Cybin’s Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move
- DEA Extends Telemedicine Rules for Controlled Substances Through 2025
- Vermont Psychedelic Therapy Advisory Working Group Kicks Can Down the Road
- Other Stories including: $PSY Sells Out, Raising $2 Million for Psychedelic Science; Johns Hopkins Launches Psilocybin Microdosing Study; New Industry Association Launches; Kentucky Ibogaine Initiative Figurehead Relocates Effort to REID Foundation; and Lawmakers in Georgia Consider Spending Up To $5 Million on Psychedelic Research for Veterans.
***
Last-Minute Rule Changes, Opt-Outs, Ahead of Colorado’s Psychedelics Program Launch
Sign-in or join Pα+ to continue reading this Issue of the Psychedelic Bulletin…
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture.
Already a member? Log In
✓ Regular Bulletins covering key topics and trends in the psychedelics space
✓ Regular articles and deep dives across psychedelic research, policy and business
✓ Interviews with insiders
✓ Monthly interactive database and commentary on psychedelic patents
✓ Quick-take analysis of major developments
✓ A Library of primers and explainers
✓ Access to our full back catalogue